(Q42987810)

12 November 2017

title

Virus inactivation during the freeze-drying processes as used for the manufacture of plasma-derived medicinal products (English)

1 reference

12 November 2017

1 reference

4

Thomas R Kreil

1 reference

12 November 2017

Ulrike Unger

1

1 reference

12 November 2017

Gerhard Poelsler

series ordinal

2

1 reference

12 November 2017

Jens Modrof

series ordinal

3

1 reference

12 November 2017

language of work or name

1 reference

19 May 2009

1 reference

12 November 2017

1 reference

12 November 2017

volume

49

1 reference

12 November 2017

issue

9

1 reference

12 November 2017

page(s)

1924-1930

1 reference

Inactivation of hepatitis A virus in plasma products by vapor heating

12 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2009.02218.X

Determination of the inactivation kinetics of hepatitis A virus in human plasma products using a simple TCID50 assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2009.02218.X

Removal/neutralization of hepatitis A virus during manufacture of high purity, solvent/detergent factor VIII concentrate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2009.02218.X

Effect of terminal (dry) heat treatment on non-enveloped viruses in coagulation factor concentrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2009.02218.X

Removal and inactivation of hepatitis A virus (HAV) during processing of factor VIII concentrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2009.02218.X

Effect of manufacturing process parameters on virus inactivation by dry heat treatment at 80 degrees C in factor VIII.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2009.02218.X

Determination of adequate moisture content for efficient dry-heat viral inactivation in lyophilized factor VIII by loss on drying and by near infrared spectroscopy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2009.02218.X

Transmission of hepatitis A to patients with hemophilia by factor VIII concentrates treated with organic solvent and detergent to inactivate viruses. The Italian Collaborative Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2009.02218.X

Review of the hepatitis A epidemics in hemophiliacs in Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2009.02218.X

Hepatitis A virus infection in tamarins: experimental transmission via contaminated factor VIII concentrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2009.02218.X

Evaluation of a new LightCycler reverse transcription-polymerase chain reaction infectivity assay for detection of human parvovirus B19 in dry-heat inactivation studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2009.02218.X

Inactivation of parvovirus B19 during STIM-4 vapor heat treatment of three coagulation factor concentrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2009.02218.X

10.1111/J.1537-2995.2009.02218.X

21 January 2018

Identifiers

DOI

1 reference

12 November 2017

1 reference